This data suggest that RF analysis of eight cytokine (IL-1β, IL-2, IL-4, IL-8, IL-10, IL-13, IFN-γ, and TNF-α) levels in serum could be used to predict MS. The gene discussed is IL13; the disease is myeloid sarcoma.